|
|
|
|
|
by vijayr02
1833 days ago
|
|
I don’t buy this explanation. There are enough publicly funded healthcare systems in the world for it to make economic sense for one of them to run a large scale trial. I don’t see an agency problem arising for such an existential threat as COVID-19. Do you see an issue with my argument? |
|
I think when you look at the selective medicare payments, the ventilator contracts, and the price of the 'recommended' patent-drugs like Remdisivir... it quickly becomes apparent that our public incentive structure is profoundly broken.